Recent health news includes a promising AstraZeneca pill for breast cancer treatment, Pfizer and Arvinas' experimental drug ...

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...

We recently published a list of Investors Rushed Into These 10 Stocks Today. In this article, we are going to take a look at ...

Billionaire Mark Cuban explains why he launched Cost Plus Drugs to fight America's opaque healthcare system by offering affordable, transparent pricing on prescription medications.

Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...

To sustain momentum, Hims recently announced a deal with Novo Nordisk A/S (NYSE: NVO) to distribute branded Wegovy at ...

Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of ...

Hims asked expert barbers for their takes on the best haircuts for a receding hairline—styles that are flattering, easy to ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...